Literature DB >> 17293243

Comparison of localization performance with implanted fiducial markers and cone-beam computed tomography for on-line image-guided radiotherapy of the prostate.

Douglas J Moseley1, Elizabeth A White, Kirsty L Wiltshire, Tara Rosewall, Michael B Sharpe, Jeffrey H Siewerdsen, Jean-Pierre Bissonnette, Mary Gospodarowicz, Padraig Warde, Charles N Catton, David A Jaffray.   

Abstract

PURPOSE: The aim of this work was to assess the accuracy of kilovoltage (kV) cone-beam computed tomography (CBCT)-based setup corrections as compared with orthogonal megavoltage (MV) portal image-based corrections for patients undergoing external-beam radiotherapy of the prostate. METHODS AND MATERIALS: Daily cone-beam CT volumetric images were acquired after setup for patients with three intraprostatic fiducial markers. The estimated couch shifts were compared retrospectively to patient adjustments based on two orthogonal MV portal images (the current clinical standard of care in our institution). The CBCT soft-tissue based shifts were also estimated by digitally removing the gold markers in each projection to suppress the artifacts in the reconstructed volumes. A total of 256 volumetric images for 15 patients were analyzed.
RESULTS: The Pearson coefficient of correlation for the patient position shifts using fiducial markers in MV vs. kV was (R2 = 0.95, 0.84, 0.81) in the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions, respectively. The correlation using soft-tissue matching was as follows: R2 = 0.90, 0.49, 0.51 in the LR, AP and SI directions. A Bland-Altman analysis showed no significant trends in the data. The percentage of shifts within a +/-3-mm tolerance (the clinical action level) was 99.7%, 95.5%, 91.3% for fiducial marker matching and 99.5%, 70.3%, 78.4% for soft-tissue matching.
CONCLUSIONS: Cone-beam CT is an accurate and precise tool for image guidance. It provides an equivalent means of patient setup correction for prostate patients with implanted gold fiducial markers. Use of the additional information provided by the visualization of soft-tissue structures is an active area of research.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17293243      PMCID: PMC1906849          DOI: 10.1016/j.ijrobp.2006.10.039

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  32 in total

1.  Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate.

Authors:  H Alasti; M P Petric; C N Catton; P R Warde
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-01       Impact factor: 7.038

2.  Cone-beam computed tomography with a flat-panel imager: initial performance characterization.

Authors:  D A Jaffray; J H Siewerdsen
Journal:  Med Phys       Date:  2000-06       Impact factor: 4.071

Review 3.  Helical tomotherapy: an innovative technology and approach to radiation therapy.

Authors:  James S Welsh; Rakesh R Patel; Mark A Ritter; Paul M Harari; T Rockwell Mackie; Minesh P Mehta
Journal:  Technol Cancer Res Treat       Date:  2002-08

Review 4.  Intensity-modulated radiation therapy for prostate cancer.

Authors:  Michael J Zelefsky; Zvi Fuks; Steven A Leibel
Journal:  Semin Radiat Oncol       Date:  2002-07       Impact factor: 5.934

5.  Flat-panel cone-beam computed tomography for image-guided radiation therapy.

Authors:  David A Jaffray; Jeffrey H Siewerdsen; John W Wong; Alvaro A Martinez
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

6.  The stability of mechanical calibration for a kV cone beam computed tomography system integrated with linear accelerator.

Authors:  Michael B Sharpe; Douglas J Moseley; Thomas G Purdie; Mohammad Islam; Jeffrey H Siewerdsen; David A Jaffray
Journal:  Med Phys       Date:  2006-01       Impact factor: 4.071

7.  Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers.

Authors:  J Wu; T Haycocks; H Alasti; G Ottewell; N Middlemiss; M Abdolell; P Warde; A Toi; C Catton
Journal:  Radiother Oncol       Date:  2001-11       Impact factor: 6.280

8.  Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy.

Authors:  Christopher F Serago; Suzanne J Chungbin; Steven J Buskirk; Gary A Ezzell; A Craig Collie; Sujay A Vora
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

9.  Implementation and utility of a daily ultrasound-based localization system with intensity-modulated radiotherapy for prostate cancer.

Authors:  Jody Morr; Thomas DiPetrillo; Jen San Tsai; Mark Engler; David E Wazer
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-08-01       Impact factor: 7.038

10.  Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation.

Authors:  Homan Dehnad; Aart J Nederveen; Uulke A van der Heide; R Jeroen A van Moorselaar; Pieter Hofman; Jan J W Lagendijk
Journal:  Radiother Oncol       Date:  2003-06       Impact factor: 6.280

View more
  68 in total

1.  Consideration of the likely benefit from implementation of prostate image-guided radiotherapy using current margin sizes: a radiobiological analysis.

Authors:  G S J Tudor; Y L Rimmer; T B Nguyen; M A Cowen; S J Thomas
Journal:  Br J Radiol       Date:  2012-02-14       Impact factor: 3.039

Review 2.  Technological advances in radiation therapy for prostate cancer.

Authors:  Mehee Choi; Arthur Y Hung
Journal:  Curr Urol Rep       Date:  2010-05       Impact factor: 3.092

3.  The impact of androgen deprivation therapy on setup errors during external beam radiation therapy for prostate cancer.

Authors:  Cem Onal; Yemliha Dolek; Yurday Ozdemir
Journal:  Strahlenther Onkol       Date:  2017-04-13       Impact factor: 3.621

4.  Phantom measurements to quantify the accuracy of a commercially available cone-beam CT gray-value matching algorithm using multiple Fiducials.

Authors:  Frederick Marc Köhler; Judit Boda-Heggemann; Beate Küpper; Dirk Wolff; Hansjörg Wertz; Frank Lohr; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-02-18       Impact factor: 3.621

Review 5.  kV cone-beam CT-based IGRT: a clinical review.

Authors:  Judit Boda-Heggemann; Frank Lohr; Frederik Wenz; Michael Flentje; Matthias Guckenberger
Journal:  Strahlenther Onkol       Date:  2011-04-26       Impact factor: 3.621

6.  Hypofractionated Radiation Therapy for Localized Prostate Cancer: An ASTRO, ASCO, and AUA Evidence-Based Guideline.

Authors:  Scott C Morgan; Karen Hoffman; D Andrew Loblaw; Mark K Buyyounouski; Caroline Patton; Daniel Barocas; Soren Bentzen; Michael Chang; Jason Efstathiou; Patrick Greany; Per Halvorsen; Bridget F Koontz; Colleen Lawton; C Marc Leyrer; Daniel Lin; Michael Ray; Howard Sandler
Journal:  J Clin Oncol       Date:  2018-10-11       Impact factor: 44.544

7.  Is it essential to use fiducial markers during cone-beam CT-based radiotherapy for prostate cancer patients?

Authors:  Berna A Yildirim; Cem Onal; Yemliha Dolek
Journal:  Jpn J Radiol       Date:  2016-10-11       Impact factor: 2.374

Review 8.  Image-guided radiotherapy: from current concept to future perspectives.

Authors:  David A Jaffray
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

9.  Verification of the dose attenuation of a newly developed vacuum cushion for intensity-modulated radiation therapy of prostate cancer.

Authors:  Toru Takakura; Yoshiyuki Ito; Akinori Higashikawa; Tomohiro Nishiyama; Takashi Sakamoto
Journal:  Radiol Phys Technol       Date:  2016-06-03

10.  Method comparison of automated matching software-assisted cone-beam CT and stereoscopic kilovoltage x-ray positional verification image-guided radiation therapy for head and neck cancer: a prospective analysis.

Authors:  Clifton D Fuller; Todd J Scarbrough; Jan-Jakob Sonke; Coen R N Rasch; Mehee Choi; Joe Y Ting; Samuel J Wang; Niko Papanikolaou; David I Rosenthal
Journal:  Phys Med Biol       Date:  2009-11-24       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.